LivaNova Investor Relations Material
Latest events
Q2 2025
LivaNova
Access the full event backlog
Slides, Transcripts, and Reports from 13,000 public companies
Latest reports from LivaNova PLC
Access all reports
LivaNova PLC is a global medical technology company that develops and manufactures devices for use in cardiovascular and neuromodulation therapies. The company’s products are designed to address critical conditions such as heart failure, obstructive sleep apnea, and epilepsy. LivaNova’s cardiovascular segment focuses on cardiac surgery and advanced circulatory support, while its neuromodulation segment offers devices for treating neurological disorders. The company is headquartered in London, England, and its shares are listed on the NASDAQ.
Key slides for LivaNova PLC
Q2 2025
LivaNova PLC
Q1 2025
LivaNova PLC
Latest articles
)
Global Doughmination: Breaking Down Domino's Pizza
Inside the rise of Domino's Pizza: how franchising, delivery control, and supply chain mastery built one of the world's most efficient food empires.
18 Jul 2025
)
The Fifteenth Generation: A Conversation with Pietro Gussalli Beretta
An interview with Pietro Gussalli Beretta on how Beretta Holding blends 500 years of tradition with global growth, innovation, and long-term vision.
10 Jul 2025
)
Citadel: Relentless Optimization at Global Scale
From a Harvard dorm to global dominance, this is the story of how Ken Griffin created one of the best-performing hedge funds of all time.
4 Jul 2025
Ticker symbol
LIVN
Country
🇺🇸 United States